<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="55143">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01651832</url>
  </required_header>
  <id_info>
    <org_study_id>01GY1143</org_study_id>
    <nct_id>NCT01651832</nct_id>
  </id_info>
  <brief_title>Supportive Cancer Care Networkers (SCAN)</brief_title>
  <acronym>SCAN</acronym>
  <official_title>Supportive Cancer Care Netwokers - a Prospective Randomized Controlled Multi-center Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Martin-Luther-Universität Halle-Wittenberg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Martin-Luther-Universität Halle-Wittenberg</source>
  <oversight_info>
    <authority>Germany: Federal Ministry of Education and Research</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim of the study is to increase the proportion of indicated patients with colorectal cancer
      undergoing adjuvant chemotherapy following surgical resection through an optimized symptom
      management and logistical support.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In order to increase the utilization of adjuvant therapies, patients in the intervention
      group are offered an additional nursing intervention in the period between discharge after
      inpatient treatment and the beginning of adjuvant therapy. This includes a telephone
      follow-up conducted according to guidelines serving to disclose patients' current supportive
      needs in order to determine potential intervention approaches as early as possible. Hence,
      the intervention aims to motivate patients not to discontinue the treatment. An early
      detection of therapy-related physical and psychological impairments aims at optimizing
      treatment management.

      Patients in the intervention group therefore are visited by nursing staff specialized in
      cancer care (Supportive Cancer Care Networkers, SCAN) during their in-patient stay and are
      informed about the intervention. An assignment for the SCAN is to support patients in
      getting access to health care services (e.g. specialists). Patients are given certain
      information, as for example contact to specialists, voluntary services and the next steps
      and appointments of the treatment plan are discussed. Within a consultation at the day
      before hospital discharge, the SCAN takes up the contact information and appoints weekly
      telephone consultations for the time up to the adjuvant therapy. The SCAN hands out
      information materials and explains the study documents, as for example patient-held records
      (PHR) in order to improve therapy compliance.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Anticipated">January 2015</completion_date>
  <primary_completion_date type="Anticipated">October 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Supportive Care</study_design>
  <primary_outcome>
    <measure>proportion of eligible patients undergoing adjuvant chemo therapy</measure>
    <time_frame>8 weeks after hospital discharge/ chrirurgical resection</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>disease-free survival</measure>
    <time_frame>8 month after hospital discharge/ chrirurgical resection</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health-related Quality of Life</measure>
    <time_frame>8 weeks &amp; 8 month after hospital discharge/ chrirurgical resection</time_frame>
    <safety_issue>No</safety_issue>
    <description>using the EORTC QLQ-C30 &amp; CR-29</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>symptom burden</measure>
    <time_frame>8 weeks &amp; 8 month after hospital discharge/ chrirurgical resection</time_frame>
    <safety_issue>No</safety_issue>
    <description>using the M.D. Anderson Symptom inventory</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Distress</measure>
    <time_frame>8 weeks &amp; 8 month after hospital discharge/ chrirurgical resection</time_frame>
    <safety_issue>No</safety_issue>
    <description>using the Distress-Thermometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>supportive care needs</measure>
    <time_frame>8 weeks &amp; 8 month after hospital discharge/ chrirurgical resection</time_frame>
    <safety_issue>No</safety_issue>
    <description>using the Supportive Needs Quastionaire-37 (FU-T)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of inpatient care</measure>
    <time_frame>at Baseline</time_frame>
    <safety_issue>No</safety_issue>
    <description>using the EORTC INPATSAT-32</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">700</enrollment>
  <condition>Colorectal Cancer</condition>
  <condition>Chemotherapy</condition>
  <arm_group>
    <arm_group_label>usual care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>routine care and case management</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SCAN-Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>SCAN</intervention_name>
    <description>The Supportive Cancer Care Networkers intervention (SCAN) consists of an additional telephone support and symptom-related out-patient care management through Oncology Nursing. The SCAN intervention assesses patients' resources and barriers in utilizing health care services in order to meet their individual needs adequately and supports maintenance of therapy compliance. Thus, the SCAN offers a comprehensive mirroring the patients' medical and psychosocial care needs across changing sectors of health care.</description>
    <arm_group_label>SCAN-Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  colorectal carcinoma (ICD-10: C18, C19, C20)

          -  indication for adjuvant chemo therapy following S3-Guideline on colorectal Cancer or
             physician-directed

          -  living in Saxony-Anhalt

          -  ECOG-Performance Status &lt;3

          -  prospective further life expectancy of more than three months

        Exclusion Criteria:

          -  unabled to read oder understand german properly

          -  any contra-indication for adjuvant therapy as described in the S3-Guideline such as
             inadequate liver, bone marrow, and kidney function or coronary heart disease (NYHA
             III-IV).
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Margarete Landenberger, Prof. Dr.</last_name>
    <role>Study Director</role>
    <affiliation>Martin-Luther-University Halle-Wittenberg, Medical Faculty, Institute for Health and Nursing Science</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alexander Bauer, Dr.</last_name>
    <phone>+49 345 557-4124</phone>
    <email>alexander.bauer@medizin.uni-halle.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Margarete Landenberger, Prof. Dr. phil. habil.</last_name>
    <phone>+49 345 557-1220</phone>
    <email>margarete.landenberger@medizin.uni-halle.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>AMEOS Klinikum Aschersleben-Staßfurt GmbH</name>
      <address>
        <city>Aschersleben</city>
        <state>Saxony-Anhalt</state>
        <zip>06449</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Wieland, Dr.</last_name>
      <phone>+49(0) 3473-971279</phone>
      <email>j.wieland@kkl.de</email>
    </contact>
    <investigator>
      <last_name>Jan Wieland, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Diakonissenkrankenhaus Dessau gGmbH</name>
      <address>
        <city>Dessau</city>
        <state>Saxony-Anhalt</state>
        <zip>06846</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jens P. May, Dr.</last_name>
      <phone>+49(0) 340-6502-2110</phone>
      <email>chirurgie@dkd-dessau.de</email>
    </contact>
    <investigator>
      <last_name>Jens P May, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Halle</name>
      <address>
        <city>Halle</city>
        <state>Saxony-Anhalt</state>
        <zip>D-06112</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jörn Rüssel, Dr.</last_name>
      <phone>+49 345 557-7223</phone>
      <email>joern.ruessel@uk-halle.de</email>
    </contact>
    <investigator>
      <last_name>Jörn Rüssel, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>HELIOS Klinik Lutherstadt Eisleben</name>
      <address>
        <city>Lutherstadt Eisleben</city>
        <state>Saxony-Anhalt</state>
        <zip>06295</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Stefan Kothe, Dr.</last_name>
      <phone>03475-901040</phone>
      <email>stefan.kothe@helios-kliniken.de</email>
    </contact>
    <investigator>
      <last_name>Stefan Kothe, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum Magdeburg gGmbH</name>
      <address>
        <city>Magdeburg</city>
        <state>Saxony-Anhalt</state>
        <zip>39130</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karsten Ridwelski, Prof. Dr.</last_name>
      <phone>+49(0) 391-7914200</phone>
      <email>karsten.ridwelski@klinikum-magdeburg.de</email>
    </contact>
    <investigator>
      <last_name>Karsten Ridwelski, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>HELIOS Klinik Sangerhausen</name>
      <address>
        <city>Sangerhausen</city>
        <state>Saxony-Anhalt</state>
        <zip>06526</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bernd Klinge, Dr.</last_name>
      <phone>+49(0) 3464-663500</phone>
      <email>bernd.klinge@helios-kliniken.de</email>
    </contact>
    <investigator>
      <last_name>Bernd Klinge, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AMEOS Klinikum Schönebeck GmbH</name>
      <address>
        <city>Schönebeck</city>
        <state>Saxony-Anhalt</state>
        <zip>39218</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andreas Thews, Dr.</last_name>
      <phone>+49 (0) 3928-641101</phone>
      <email>darmzentrum@kh-sbk.de</email>
    </contact>
    <investigator>
      <last_name>Andreas Thews, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Carl-von-Basedow-Klinikum Merseburg</name>
      <address>
        <city>Merseburg</city>
        <state>Saxony-Anhat</state>
        <zip>06217</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sven Hake, Dr.</last_name>
      <phone>+49(0) 3461-274500</phone>
      <email>s.hake@klinikum-saalekreis.de</email>
    </contact>
    <investigator>
      <last_name>Sven Hake, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <lastchanged_date>April 18, 2013</lastchanged_date>
  <firstreceived_date>July 25, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Martin-Luther-Universität Halle-Wittenberg</investigator_affiliation>
    <investigator_full_name>Alexander Bauer</investigator_full_name>
    <investigator_title>Scientific Research Fellow</investigator_title>
  </responsible_party>
  <keyword>Colorectal Neoplasms/*drug therapy/*secondary</keyword>
  <keyword>Health Services Accessibility</keyword>
  <keyword>Humans</keyword>
  <keyword>Supportive Care Needs</keyword>
  <keyword>Psychooncology</keyword>
  <keyword>Rural Population</keyword>
  <keyword>Primary Health Care/*methods</keyword>
  <keyword>Treatment Outcome</keyword>
  <keyword>Socioeconomic Factors</keyword>
  <keyword>Quality Assurance, Health Care</keyword>
  <keyword>Quality of Life</keyword>
  <keyword>Adult</keyword>
  <keyword>Aged</keyword>
  <keyword>Aged, 80 and over</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
